Institutional Review Board “Checklist” offers tool to help protect clinical trial participants
FDA and OHRP Finalize Joint Guidance on IRB Meeting Minutes
Do the Waive – FDA Implements Informed Consent Waivers for Minimal Risk Studies
Regional Accrediting Agency Proposes Ban on Paying Recruiters of International Students
HHS Overhauls the Common Rule to Enhance Protection for Human Subjects in Research
“Institutional Review Board (IRB) Written Procedures” Draft Guidance and NIH’s “Single IRB Policy” Offer Food for Thought to IRBs Charged with Oversight of Human Subjects Research
NIH and FDA Announce Release of Draft Clinical Trial Protocol Template; Call for Comments by April 17, 2016
NSF and NASA Remind Grantee Institutions to Comply with Title IX
New HHS OIG Work Plan Indicates Focus on Subrecipient Monitoring
Subscribe: Subscribe via RSS
Blogs
Firm/Org